Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioMatrix provides commercial specialty infusion services nationwide with a focus on high-touch patient management for chronic and complex conditions. The company has demonstrated significant growth through organic expansion and acquisitions. It recently acquired MyLyfe Health to further strengthen its position in ambulatory/home infusion services. In early 2023, it divested its oral specialty business to focus exclusively on home-based specialty infusions. No clinical trial results are reported as it operates as a service provider rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioMatrix Specialty Infusion Pharmacy.